Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

ACL Reconstruction Market by Procedure Type (Graft Fixation, Autograft, Allograft), by Fixation Type (Femoral, Tibial) and by End Users (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2023-2032

A08409

Pages: NA

Charts: NA

Tables: NA

ACL reconstruction is a surgery that replaces a torn Anterior Cruciate Ligament (ACL), which is a major ligament in knee. Anterior Cruciate ligament (ACL) is made of tough fibrous materials, which are located in the knee joint. ACL is a ligament that passes through the middle of the knee and connects thighbone to shinbone, which stabilizes the knee joint. ACL injuries occur due to various sports that involve sudden halts and changes in direction such as basketball, football, soccer, downhill skiing, gymnastics, etc. In surgeries, the torn ligament is replaced with a tendon from another part of the knee or some deceased donor. This is an outpatient procedure and is performed through small incisions around the knee joint. A doctor who specializes in surgical procedures of the bones and joints, i.e. orthopedic surgeon operates the ACL reconstruction surgery. ACL reconstruction can be done via surgical or nonsurgical ways.

COVID-19 scenario analysis:

  • To take care of the infected population, the demand for medical supplies is increasing. Respiratory support devices, such as atomizer, life-support machine, oxygen generator, and monitor, are among the majorly used medical devices in primary clinical treatment. 
  • Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in the number of COVID-19 cases worldwide, the need for medical supplies keeps on rising both from healthcare professionals and civil populations for precautionary measures. 
  • Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.
  • Attributed to such factors, COVID-19 is expected to have a significant impact on the market.

Top impacting factors: Market scenario analysis, trends, drivers, and impact analysis

Increase in injuries and prevalence caused by sports, launch, and addition of new techniques and devices are the major factors affecting the ACL reconstruction market positively. The growing participation of children in sport activities and organized sports, such as football, soccer, and basketball, is result in a higher incidence of ACL injuries, and is generally observed in skeletally immature athletes. This rise in number of ACL injury cases is setting in motion the demand for knee reconstruction devices. There are also various advances in the techniques for surgery, increase in geriatric population with rise in level of obesity and various diseases that are expected to drive the ACL reconstruction market growth. In addition, there have been various R&D activities going on with innovative therapies and different product launches, thereby boosting the growth of the knee reconstruction market. On the other hand, expensive knee-related surgeries in developing and underdeveloped countries where the compensation rates are low with poor healthcare systems are the major challenges for patients.

New product launches to boost the market

On August 23rd, 2019, Fuse Medical launched a new Sterizo Total Knee Replacement System. It is the latest technology and offers a wide range of size and multi stabilization options such as ‘Cruciate Retained’, ‘Ultra Congruent Anterior Stabilized’, and Posterior Stabilized. This benefits the surgeons in performing the total knee replacement therapy. On April 10th, 2017, Microport Orthopedics introduced two new knee replacement-based products “Evolution Revision Tibial System” and “Evolution BioFoam Tibia”. These products fix the low quality of bone stock and surgeons can broaden choices while treating their patients.

Surge in usage in hospital applications

Increase in players in the sports field gave rise to an exponential growth in ACL injury cases, which increases the demand for ACL reconstruction devices and techniques in hospitals.

Key benefits of the report:

  • This study presents the analytical depiction of the ACL reconstruction market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the ACL reconstruction market share.
  • The current market is quantitatively analyzed to highlight the ACL reconstruction market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the ACL reconstruction market research report:

  • Which are the leading market players active in the ACL reconstruction market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What are the projections for the future that would help in taking further strategic steps?

 Key Market Segments

  • By Procedure Type
    • Graft Fixation
    • Autograft
    • Allograft
  • By Fixation Type
    • Femoral
      • Tissue Fixation
      • Bone Fixation
    • Tibial
      • Tissue Fixation
      • Bone Fixation
  • By End Users
    • Hospitals
    • Orthopedic Clinics
    • Ambulatory Surgical Centers
  • By Region
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • rest of LATAM
    • the Middle East
    • Africa

 
Key Market Players

  • Japan Medical Dynamic Marketing
  • Smith & Nephew
  • DePuy Synthes
  • Arthrex Inc.
  • United Orthopedic Corporation
  • DJO Global
  • Tornier Inc.
  • Corin
  • Exactech Inc.
  • Stryker Corporation

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: ACL RECONSTRUCTION MARKET, BY PROCEDURE TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Procedure Type

    • 4.2. Graft Fixation

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Autograft

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Allograft

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: ACL RECONSTRUCTION MARKET, BY FIXATION TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Fixation Type

    • 5.2. Femoral

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

      • 5.2.4. Tissue Fixation

        • 5.2.4.1. Market Size and Forecast

      • 5.2.4. Bone Fixation

        • 5.2.4.1. Market Size and Forecast

    • 5.3. Tibial

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

      • 5.3.4. Tissue Fixation

        • 5.3.4.1. Market Size and Forecast

      • 5.3.4. Bone Fixation

        • 5.3.4.1. Market Size and Forecast

  • CHAPTER 6: ACL RECONSTRUCTION MARKET, BY END USERS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End Users

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Orthopedic Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Ambulatory Surgical Centers

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: ACL RECONSTRUCTION MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Procedure Type

      • 7.2.3. Market Size and Forecast, By Fixation Type

      • 7.2.4. Market Size and Forecast, By End Users

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Acl Reconstruction Market

        • 7.2.6.1. Market Size and Forecast, By Procedure Type
        • 7.2.6.2. Market Size and Forecast, By Fixation Type
        • 7.2.6.3. Market Size and Forecast, By End Users

      • 7.2.7. Canada Acl Reconstruction Market

        • 7.2.7.1. Market Size and Forecast, By Procedure Type
        • 7.2.7.2. Market Size and Forecast, By Fixation Type
        • 7.2.7.3. Market Size and Forecast, By End Users

      • 7.2.8. Mexico Acl Reconstruction Market

        • 7.2.8.1. Market Size and Forecast, By Procedure Type
        • 7.2.8.2. Market Size and Forecast, By Fixation Type
        • 7.2.8.3. Market Size and Forecast, By End Users

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Procedure Type

      • 7.3.3. Market Size and Forecast, By Fixation Type

      • 7.3.4. Market Size and Forecast, By End Users

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Acl Reconstruction Market

        • 7.3.6.1. Market Size and Forecast, By Procedure Type
        • 7.3.6.2. Market Size and Forecast, By Fixation Type
        • 7.3.6.3. Market Size and Forecast, By End Users

      • 7.3.7. Germany Acl Reconstruction Market

        • 7.3.7.1. Market Size and Forecast, By Procedure Type
        • 7.3.7.2. Market Size and Forecast, By Fixation Type
        • 7.3.7.3. Market Size and Forecast, By End Users

      • 7.3.8. Italy Acl Reconstruction Market

        • 7.3.8.1. Market Size and Forecast, By Procedure Type
        • 7.3.8.2. Market Size and Forecast, By Fixation Type
        • 7.3.8.3. Market Size and Forecast, By End Users

      • 7.3.9. Spain Acl Reconstruction Market

        • 7.3.9.1. Market Size and Forecast, By Procedure Type
        • 7.3.9.2. Market Size and Forecast, By Fixation Type
        • 7.3.9.3. Market Size and Forecast, By End Users

      • 7.3.10. UK Acl Reconstruction Market

        • 7.3.10.1. Market Size and Forecast, By Procedure Type
        • 7.3.10.2. Market Size and Forecast, By Fixation Type
        • 7.3.10.3. Market Size and Forecast, By End Users

      • 7.3.11. Russia Acl Reconstruction Market

        • 7.3.11.1. Market Size and Forecast, By Procedure Type
        • 7.3.11.2. Market Size and Forecast, By Fixation Type
        • 7.3.11.3. Market Size and Forecast, By End Users

      • 7.3.12. Rest Of Europe Acl Reconstruction Market

        • 7.3.12.1. Market Size and Forecast, By Procedure Type
        • 7.3.12.2. Market Size and Forecast, By Fixation Type
        • 7.3.12.3. Market Size and Forecast, By End Users

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Procedure Type

      • 7.4.3. Market Size and Forecast, By Fixation Type

      • 7.4.4. Market Size and Forecast, By End Users

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Acl Reconstruction Market

        • 7.4.6.1. Market Size and Forecast, By Procedure Type
        • 7.4.6.2. Market Size and Forecast, By Fixation Type
        • 7.4.6.3. Market Size and Forecast, By End Users

      • 7.4.7. Japan Acl Reconstruction Market

        • 7.4.7.1. Market Size and Forecast, By Procedure Type
        • 7.4.7.2. Market Size and Forecast, By Fixation Type
        • 7.4.7.3. Market Size and Forecast, By End Users

      • 7.4.8. India Acl Reconstruction Market

        • 7.4.8.1. Market Size and Forecast, By Procedure Type
        • 7.4.8.2. Market Size and Forecast, By Fixation Type
        • 7.4.8.3. Market Size and Forecast, By End Users

      • 7.4.9. South Korea Acl Reconstruction Market

        • 7.4.9.1. Market Size and Forecast, By Procedure Type
        • 7.4.9.2. Market Size and Forecast, By Fixation Type
        • 7.4.9.3. Market Size and Forecast, By End Users

      • 7.4.10. Australia Acl Reconstruction Market

        • 7.4.10.1. Market Size and Forecast, By Procedure Type
        • 7.4.10.2. Market Size and Forecast, By Fixation Type
        • 7.4.10.3. Market Size and Forecast, By End Users

      • 7.4.11. Thailand Acl Reconstruction Market

        • 7.4.11.1. Market Size and Forecast, By Procedure Type
        • 7.4.11.2. Market Size and Forecast, By Fixation Type
        • 7.4.11.3. Market Size and Forecast, By End Users

      • 7.4.12. Malaysia Acl Reconstruction Market

        • 7.4.12.1. Market Size and Forecast, By Procedure Type
        • 7.4.12.2. Market Size and Forecast, By Fixation Type
        • 7.4.12.3. Market Size and Forecast, By End Users

      • 7.4.13. Indonesia Acl Reconstruction Market

        • 7.4.13.1. Market Size and Forecast, By Procedure Type
        • 7.4.13.2. Market Size and Forecast, By Fixation Type
        • 7.4.13.3. Market Size and Forecast, By End Users

      • 7.4.14. Rest of Asia Pacific Acl Reconstruction Market

        • 7.4.14.1. Market Size and Forecast, By Procedure Type
        • 7.4.14.2. Market Size and Forecast, By Fixation Type
        • 7.4.14.3. Market Size and Forecast, By End Users

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Procedure Type

      • 7.5.3. Market Size and Forecast, By Fixation Type

      • 7.5.4. Market Size and Forecast, By End Users

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Acl Reconstruction Market

        • 7.5.6.1. Market Size and Forecast, By Procedure Type
        • 7.5.6.2. Market Size and Forecast, By Fixation Type
        • 7.5.6.3. Market Size and Forecast, By End Users

      • 7.5.7. South Africa Acl Reconstruction Market

        • 7.5.7.1. Market Size and Forecast, By Procedure Type
        • 7.5.7.2. Market Size and Forecast, By Fixation Type
        • 7.5.7.3. Market Size and Forecast, By End Users

      • 7.5.8. Saudi Arabia Acl Reconstruction Market

        • 7.5.8.1. Market Size and Forecast, By Procedure Type
        • 7.5.8.2. Market Size and Forecast, By Fixation Type
        • 7.5.8.3. Market Size and Forecast, By End Users

      • 7.5.9. UAE Acl Reconstruction Market

        • 7.5.9.1. Market Size and Forecast, By Procedure Type
        • 7.5.9.2. Market Size and Forecast, By Fixation Type
        • 7.5.9.3. Market Size and Forecast, By End Users

      • 7.5.10. Argentina Acl Reconstruction Market

        • 7.5.10.1. Market Size and Forecast, By Procedure Type
        • 7.5.10.2. Market Size and Forecast, By Fixation Type
        • 7.5.10.3. Market Size and Forecast, By End Users

      • 7.5.11. Rest of LAMEA Acl Reconstruction Market

        • 7.5.11.1. Market Size and Forecast, By Procedure Type
        • 7.5.11.2. Market Size and Forecast, By Fixation Type
        • 7.5.11.3. Market Size and Forecast, By End Users

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Stryker Corporation

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. DePuy Synthes

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Smith And Nephew

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Corin

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. United Orthopedic Corporation

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Arthrex Inc.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Exactech Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. DJO Global

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Japan Medical Dynamic Marketing

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Tornier Inc.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ACL RECONSTRUCTION MARKET, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL ACL RECONSTRUCTION MARKET FOR GRAFT FIXATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL ACL RECONSTRUCTION MARKET FOR AUTOGRAFT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL ACL RECONSTRUCTION MARKET FOR ALLOGRAFT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL ACL RECONSTRUCTION MARKET, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL ACL RECONSTRUCTION MARKET FOR FEMORAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL ACL RECONSTRUCTION MARKET FOR TIBIAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL ACL RECONSTRUCTION MARKET, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL ACL RECONSTRUCTION MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL ACL RECONSTRUCTION MARKET FOR ORTHOPEDIC CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL ACL RECONSTRUCTION MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL ACL RECONSTRUCTION MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA ACL RECONSTRUCTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 17. U.S. ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 18. U.S. ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 19. U.S. ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 20. CANADA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 21. CANADA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 22. CANADA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE ACL RECONSTRUCTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 32. FRANCE ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 33. GERMANY ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 35. GERMANY ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 36. ITALY ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 37. ITALY ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 38. ITALY ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 39. SPAIN ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 40. SPAIN ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 41. SPAIN ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 42. UK ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 43. UK ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 44. UK ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 45. RUSSIA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 46. RUSSIA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 47. RUSSIA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 48. REST OF EUROPE ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 50. REST OF EUROPE ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 51. ASIA-PACIFIC ACL RECONSTRUCTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 55. CHINA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 56. CHINA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 57. CHINA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 58. JAPAN ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 59. JAPAN ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 60. JAPAN ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 61. INDIA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 62. INDIA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 63. INDIA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH KOREA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH KOREA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 67. AUSTRALIA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 68. AUSTRALIA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 69. AUSTRALIA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 70. THAILAND ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 71. THAILAND ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 72. THAILAND ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 73. MALAYSIA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 74. MALAYSIA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 75. MALAYSIA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 76. INDONESIA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 77. INDONESIA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 78. INDONESIA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 82. LAMEA ACL RECONSTRUCTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 86. BRAZIL ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 87. BRAZIL ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 88. BRAZIL ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH AFRICA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH AFRICA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH AFRICA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 92. SAUDI ARABIA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 93. SAUDI ARABIA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 94. SAUDI ARABIA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 95. UAE ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 96. UAE ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 97. UAE ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 98. ARGENTINA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 99. ARGENTINA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 100. ARGENTINA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 101. REST OF LAMEA ACL RECONSTRUCTION, BY PROCEDURE TYPE, 2025-2033 ($MILLION)
  • TABLE 102. REST OF LAMEA ACL RECONSTRUCTION, BY FIXATION TYPE, 2025-2033 ($MILLION)
  • TABLE 103. REST OF LAMEA ACL RECONSTRUCTION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 104. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 105. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 106. STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 107. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 108. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. DEPUY SYNTHES: KEY EXECUTIVES
  • TABLE 110. DEPUY SYNTHES: COMPANY SNAPSHOT
  • TABLE 111. DEPUY SYNTHES: OPERATING SEGMENTS
  • TABLE 112. DEPUY SYNTHES: PRODUCT PORTFOLIO
  • TABLE 113. DEPUY SYNTHES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 115. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 116. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 117. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 118. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. CORIN: KEY EXECUTIVES
  • TABLE 120. CORIN: COMPANY SNAPSHOT
  • TABLE 121. CORIN: OPERATING SEGMENTS
  • TABLE 122. CORIN: PRODUCT PORTFOLIO
  • TABLE 123. CORIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. UNITED ORTHOPEDIC CORPORATION: KEY EXECUTIVES
  • TABLE 125. UNITED ORTHOPEDIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 126. UNITED ORTHOPEDIC CORPORATION: OPERATING SEGMENTS
  • TABLE 127. UNITED ORTHOPEDIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 128. UNITED ORTHOPEDIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. ARTHREX INC.: KEY EXECUTIVES
  • TABLE 130. ARTHREX INC.: COMPANY SNAPSHOT
  • TABLE 131. ARTHREX INC.: OPERATING SEGMENTS
  • TABLE 132. ARTHREX INC.: PRODUCT PORTFOLIO
  • TABLE 133. ARTHREX INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. EXACTECH INC.: KEY EXECUTIVES
  • TABLE 135. EXACTECH INC.: COMPANY SNAPSHOT
  • TABLE 136. EXACTECH INC.: OPERATING SEGMENTS
  • TABLE 137. EXACTECH INC.: PRODUCT PORTFOLIO
  • TABLE 138. EXACTECH INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. DJO GLOBAL: KEY EXECUTIVES
  • TABLE 140. DJO GLOBAL: COMPANY SNAPSHOT
  • TABLE 141. DJO GLOBAL: OPERATING SEGMENTS
  • TABLE 142. DJO GLOBAL: PRODUCT PORTFOLIO
  • TABLE 143. DJO GLOBAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. JAPAN MEDICAL DYNAMIC MARKETING: KEY EXECUTIVES
  • TABLE 145. JAPAN MEDICAL DYNAMIC MARKETING: COMPANY SNAPSHOT
  • TABLE 146. JAPAN MEDICAL DYNAMIC MARKETING: OPERATING SEGMENTS
  • TABLE 147. JAPAN MEDICAL DYNAMIC MARKETING: PRODUCT PORTFOLIO
  • TABLE 148. JAPAN MEDICAL DYNAMIC MARKETING: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. TORNIER INC.: KEY EXECUTIVES
  • TABLE 150. TORNIER INC.: COMPANY SNAPSHOT
  • TABLE 151. TORNIER INC.: OPERATING SEGMENTS
  • TABLE 152. TORNIER INC.: PRODUCT PORTFOLIO
  • TABLE 153. TORNIER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ACL RECONSTRUCTION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ACL RECONSTRUCTION MARKET
  • FIGURE 3. SEGMENTATION ACL RECONSTRUCTION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ACL RECONSTRUCTION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALACL RECONSTRUCTION MARKET
  • FIGURE 11. ACL RECONSTRUCTION MARKET SEGMENTATION, BY BY PROCEDURE TYPE
  • FIGURE 12. ACL RECONSTRUCTION MARKET FOR GRAFT FIXATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. ACL RECONSTRUCTION MARKET FOR AUTOGRAFT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. ACL RECONSTRUCTION MARKET FOR ALLOGRAFT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. ACL RECONSTRUCTION MARKET SEGMENTATION, BY BY FIXATION TYPE
  • FIGURE 16. ACL RECONSTRUCTION MARKET FOR FEMORAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. ACL RECONSTRUCTION MARKET FOR TIBIAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. ACL RECONSTRUCTION MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 19. ACL RECONSTRUCTION MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. ACL RECONSTRUCTION MARKET FOR ORTHOPEDIC CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. ACL RECONSTRUCTION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: ACL RECONSTRUCTION MARKET
  • FIGURE 28. TOP PLAYER POSITIONING, 2024
  • FIGURE 29. STRYKER CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. DEPUY SYNTHES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. DEPUY SYNTHES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. DEPUY SYNTHES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. SMITH AND NEPHEW: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. CORIN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. CORIN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. CORIN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. UNITED ORTHOPEDIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. UNITED ORTHOPEDIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. UNITED ORTHOPEDIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. ARTHREX INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. ARTHREX INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. ARTHREX INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. EXACTECH INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. EXACTECH INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. EXACTECH INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. DJO GLOBAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. DJO GLOBAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. DJO GLOBAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. JAPAN MEDICAL DYNAMIC MARKETING: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. JAPAN MEDICAL DYNAMIC MARKETING: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. JAPAN MEDICAL DYNAMIC MARKETING: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. TORNIER INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. TORNIER INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. TORNIER INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
ACL Reconstruction Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved